News
Emerald Bioscience to Present at the KCSA Cannabis Investor Conference
8:30 am ET January 5, 2021 (Globe Newswire) Print
Emerald Bioscience, Inc. (OTCQB: EMBI) ("Emerald" or the "Company"), a biopharmaceutical company focused on developing differentiated, proprietary cannabinoid derived molecules to treat glaucoma and other diseases with significant unmet needs, announced today that Punit Dhillon, CEO, Emerald Bioscience will be presenting at the KCSA Cannabis Investor Conference on Thursday, January 7, 2021.
Presentation details are as follows:
Event: KCSA Cannabis Investor Conference
Presentation Date: Thursday, January 7, 2021
Presentation Time: 2:30 - 3:00 PM ET
This will be an interactive online event where investors are invited to ask the Company questions in real-time. If attendees